We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Proposed NJ Rule to Limit Drugmaker Payment to Doctors Could Hurt Drug Development, ACRO Warns
Proposed NJ Rule to Limit Drugmaker Payment to Doctors Could Hurt Drug Development, ACRO Warns
The Association of Clinical Research Organizations warned that the state of New Jersey’s plan to cap drugmaker payments to doctors may hold unintended consequences for drug development efforts.